由于需求高且成功,新加坡延长了药品流感疫苗方案。 Singapore extends its pharmacy flu vaccine program due to high demand and success.

2024年10月在零售药店启动的新加坡流感疫苗接种试验将持续到最初的一年期计划之后, Singapore’s flu vaccination trial at retail pharmacies, launched in October 2024, will continue beyond its initial one-year plan due to strong public uptake and positive outcomes. 截至7月31日,约有1 200个疫苗被接种,远远超过200个目标——主要是新加坡公民接受政府补贴的比率。 As of July 31, about 1,200 vaccines were administered—well above the 200-target—mostly to Singapore citizens receiving government-subsidized rates. 由药剂师有效管理的不良反应微乎其微,主要是病痛。 Adverse reactions were minimal, mainly soreness, managed effectively by pharmacists. 该方案现已扩大到八个站点,将接受长期一体化审查,药店连锁店准备培训更多的经认证的疫苗接种员。 The program, now expanded to eight outlets, will be reviewed for long-term integration, with pharmacy chains preparing to train more certified vaccinators. 建议每年发射流感疫苗,因为疫苗接种两周后,即11月(2月)和5月(7月)的高峰季节开始提供保护。 Annual flu shots are recommended, as protection begins two weeks after vaccination, with peak seasons in November–February and May–July.